Industry Research Reports
Home > Reports > Chemical & Material > Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-01-13
Pages: 93 Pages
Report ld: 3496676
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
North American market for Lasmiditan Succinate was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lasmiditan Succinate was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Lasmiditan Succinate was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Lasmiditan Succinate include Molnova, Excenen Pharmatech, Hubei Gedian Humanwell Pharma, Nantong HI-FUTURE Biology, ShiJiaZhuang Chirals Chemical, Shenzhen Shengda Pharma Limited, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Lasmiditan Succinate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lasmiditan Succinate by region & country, by Type, and by Application.
The Lasmiditan Succinate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lasmiditan Succinate.
MARKET SEGMENTATION
By Company
- Molnova
- Excenen Pharmatech
- Hubei Gedian Humanwell Pharma
- Nantong HI-FUTURE Biology
- ShiJiaZhuang Chirals Chemical
- Shenzhen Shengda Pharma Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity ≥98%
- Purity ≥99%
Segment by Application
- Tablet
- Oral Liquid
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lasmiditan Succinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lasmiditan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lasmiditan Succinate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Lasmiditan Succinate Product Introduction
1.2 Global Lasmiditan Succinate Market Size Forecast
1.2.1 Global Lasmiditan Succinate Sales Value (2020-2031)
1.2.2 Global Lasmiditan Succinate Sales Volume (2020-2031)
1.2.3 Global Lasmiditan Succinate Sales Price (2020-2031)
1.3 Lasmiditan Succinate Market Trends & Drivers
1.3.1 Lasmiditan Succinate Industry Trends
1.3.2 Lasmiditan Succinate Market Drivers & Opportunity
1.3.3 Lasmiditan Succinate Market Challenges
1.3.4 Lasmiditan Succinate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lasmiditan Succinate Players Revenue Ranking (2024)
2.2 Global Lasmiditan Succinate Revenue by Company (2020-2025)
2.3 Global Lasmiditan Succinate Players Sales Volume Ranking (2024)
2.4 Global Lasmiditan Succinate Sales Volume by Company Players (2020-2025)
2.5 Global Lasmiditan Succinate Average Price by Company (2020-2025)
2.6 Key Manufacturers Lasmiditan Succinate Manufacturing Base and Headquarters
2.7 Key Manufacturers Lasmiditan Succinate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lasmiditan Succinate
2.9 Lasmiditan Succinate Market Competitive Analysis
2.9.1 Lasmiditan Succinate Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Lasmiditan Succinate Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lasmiditan Succinate as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity ≥98%
3.1.2 Purity ≥99%
3.2 Global Lasmiditan Succinate Sales Value by Type
3.2.1 Global Lasmiditan Succinate Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Lasmiditan Succinate Sales Value, by Type (2020-2031)
3.2.3 Global Lasmiditan Succinate Sales Value, by Type (%) (2020-2031)
3.3 Global Lasmiditan Succinate Sales Volume by Type
3.3.1 Global Lasmiditan Succinate Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Lasmiditan Succinate Sales Volume, by Type (2020-2031)
3.3.3 Global Lasmiditan Succinate Sales Volume, by Type (%) (2020-2031)
3.4 Global Lasmiditan Succinate Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Oral Liquid
4.2 Global Lasmiditan Succinate Sales Value by Application
4.2.1 Global Lasmiditan Succinate Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Lasmiditan Succinate Sales Value, by Application (2020-2031)
4.2.3 Global Lasmiditan Succinate Sales Value, by Application (%) (2020-2031)
4.3 Global Lasmiditan Succinate Sales Volume by Application
4.3.1 Global Lasmiditan Succinate Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Lasmiditan Succinate Sales Volume, by Application (2020-2031)
4.3.3 Global Lasmiditan Succinate Sales Volume, by Application (%) (2020-2031)
4.4 Global Lasmiditan Succinate Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Lasmiditan Succinate Sales Value by Region
5.1.1 Global Lasmiditan Succinate Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Lasmiditan Succinate Sales Value by Region (2020-2025)
5.1.3 Global Lasmiditan Succinate Sales Value by Region (2026-2031)
5.1.4 Global Lasmiditan Succinate Sales Value by Region (%), (2020-2031)
5.2 Global Lasmiditan Succinate Sales Volume by Region
5.2.1 Global Lasmiditan Succinate Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Lasmiditan Succinate Sales Volume by Region (2020-2025)
5.2.3 Global Lasmiditan Succinate Sales Volume by Region (2026-2031)
5.2.4 Global Lasmiditan Succinate Sales Volume by Region (%), (2020-2031)
5.3 Global Lasmiditan Succinate Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Lasmiditan Succinate Sales Value, 2020-2031
5.4.2 North America Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Lasmiditan Succinate Sales Value, 2020-2031
5.5.2 Europe Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Lasmiditan Succinate Sales Value, 2020-2031
5.6.2 Asia Pacific Lasmiditan Succinate Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Lasmiditan Succinate Sales Value, 2020-2031
5.7.2 South America Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lasmiditan Succinate Sales Value, 2020-2031
5.8.2 Middle East & Africa Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lasmiditan Succinate Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Lasmiditan Succinate Sales Value
6.2.1 Key Countries/Regions Lasmiditan Succinate Sales Value, 2020-2031
6.2.2 Key Countries/Regions Lasmiditan Succinate Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Lasmiditan Succinate Sales Value, 2020-2031
6.3.2 United States Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Lasmiditan Succinate Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Lasmiditan Succinate Sales Value, 2020-2031
6.4.2 Europe Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Lasmiditan Succinate Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Lasmiditan Succinate Sales Value, 2020-2031
6.5.2 China Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
6.5.3 China Lasmiditan Succinate Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Lasmiditan Succinate Sales Value, 2020-2031
6.6.2 Japan Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Lasmiditan Succinate Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Lasmiditan Succinate Sales Value, 2020-2031
6.7.2 South Korea Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Lasmiditan Succinate Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Lasmiditan Succinate Sales Value, 2020-2031
6.8.2 Southeast Asia Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Lasmiditan Succinate Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Lasmiditan Succinate Sales Value, 2020-2031
6.9.2 India Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
6.9.3 India Lasmiditan Succinate Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Molnova
7.1.1 Molnova Company Information
7.1.2 Molnova Introduction and Business Overview
7.1.3 Molnova Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Molnova Lasmiditan Succinate Product Offerings
7.1.5 Molnova Recent Development
7.2 Excenen Pharmatech
7.2.1 Excenen Pharmatech Company Information
7.2.2 Excenen Pharmatech Introduction and Business Overview
7.2.3 Excenen Pharmatech Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Excenen Pharmatech Lasmiditan Succinate Product Offerings
7.2.5 Excenen Pharmatech Recent Development
7.3 Hubei Gedian Humanwell Pharma
7.3.1 Hubei Gedian Humanwell Pharma Company Information
7.3.2 Hubei Gedian Humanwell Pharma Introduction and Business Overview
7.3.3 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Product Offerings
7.3.5 Hubei Gedian Humanwell Pharma Recent Development
7.4 Nantong HI-FUTURE Biology
7.4.1 Nantong HI-FUTURE Biology Company Information
7.4.2 Nantong HI-FUTURE Biology Introduction and Business Overview
7.4.3 Nantong HI-FUTURE Biology Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Nantong HI-FUTURE Biology Lasmiditan Succinate Product Offerings
7.4.5 Nantong HI-FUTURE Biology Recent Development
7.5 ShiJiaZhuang Chirals Chemical
7.5.1 ShiJiaZhuang Chirals Chemical Company Information
7.5.2 ShiJiaZhuang Chirals Chemical Introduction and Business Overview
7.5.3 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Product Offerings
7.5.5 ShiJiaZhuang Chirals Chemical Recent Development
7.6 Shenzhen Shengda Pharma Limited
7.6.1 Shenzhen Shengda Pharma Limited Company Information
7.6.2 Shenzhen Shengda Pharma Limited Introduction and Business Overview
7.6.3 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Product Offerings
7.6.5 Shenzhen Shengda Pharma Limited Recent Development
8 Industry Chain Analysis
8.1 Lasmiditan Succinate Industrial Chain
8.2 Lasmiditan Succinate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lasmiditan Succinate Sales Model
8.5.2 Sales Channel
8.5.3 Lasmiditan Succinate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Lasmiditan Succinate Market Trends
Table 2. Lasmiditan Succinate Market Drivers & Opportunity
Table 3. Lasmiditan Succinate Market Challenges
Table 4. Lasmiditan Succinate Market Restraints
Table 5. Global Lasmiditan Succinate Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Lasmiditan Succinate Revenue Market Share by Company (2020-2025)
Table 7. Global Lasmiditan Succinate Sales Volume by Company (2020-2025) & (Kg)
Table 8. Global Lasmiditan Succinate Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Lasmiditan Succinate Price by Company (2020-2025) & (US$/g)
Table 10. Key Manufacturers Lasmiditan Succinate Manufacturing Base and Headquarters
Table 11. Key Manufacturers Lasmiditan Succinate Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Lasmiditan Succinate
Table 13. Global Lasmiditan Succinate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lasmiditan Succinate as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Lasmiditan Succinate Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Lasmiditan Succinate Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Lasmiditan Succinate Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Lasmiditan Succinate Sales Market Share in Value by Type (2020-2025)
Table 20. Global Lasmiditan Succinate Sales Market Share in Value by Type (2026-2031)
Table 21. Global Lasmiditan Succinate Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
Table 22. Global Lasmiditan Succinate Sales Volume by Type (2020-2025) & (Kg)
Table 23. Global Lasmiditan Succinate Sales Volume by Type (2026-2031) & (Kg)
Table 24. Global Lasmiditan Succinate Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Lasmiditan Succinate Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Lasmiditan Succinate Price by Type (2020-2025) & (US$/g)
Table 27. Global Lasmiditan Succinate Price by Type (2026-2031) & (US$/g)
Table 28. Global Lasmiditan Succinate Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Lasmiditan Succinate Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Lasmiditan Succinate Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Lasmiditan Succinate Sales Market Share in Value by Application (2020-2025)
Table 32. Global Lasmiditan Succinate Sales Market Share in Value by Application (2026-2031)
Table 33. Global Lasmiditan Succinate Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
Table 34. Global Lasmiditan Succinate Sales Volume by Application (2020-2025) & (Kg)
Table 35. Global Lasmiditan Succinate Sales Volume by Application (2026-2031) & (Kg)
Table 36. Global Lasmiditan Succinate Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Lasmiditan Succinate Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Lasmiditan Succinate Price by Application (2020-2025) & (US$/g)
Table 39. Global Lasmiditan Succinate Price by Application (2026-2031) & (US$/g)
Table 40. Global Lasmiditan Succinate Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Lasmiditan Succinate Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Lasmiditan Succinate Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Lasmiditan Succinate Sales Value by Region (2020-2025) & (%)
Table 44. Global Lasmiditan Succinate Sales Value by Region (2026-2031) & (%)
Table 45. Global Lasmiditan Succinate Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
Table 46. Global Lasmiditan Succinate Sales Volume by Region (2020-2025) & (Kg)
Table 47. Global Lasmiditan Succinate Sales Volume by Region (2026-2031) & (Kg)
Table 48. Global Lasmiditan Succinate Sales Volume by Region (2020-2025) & (%)
Table 49. Global Lasmiditan Succinate Sales Volume by Region (2026-2031) & (%)
Table 50. Global Lasmiditan Succinate Average Price by Region (2020-2025) & (US$/g)
Table 51. Global Lasmiditan Succinate Average Price by Region (2026-2031) & (US$/g)
Table 52. Key Countries/Regions Lasmiditan Succinate Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Lasmiditan Succinate Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Lasmiditan Succinate Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Lasmiditan Succinate Sales Volume, (2020-2025) & (Kg)
Table 56. Key Countries/Regions Lasmiditan Succinate Sales Volume, (2026-2031) & (Kg)
Table 57. Molnova Company Information
Table 58. Molnova Introduction and Business Overview
Table 59. Molnova Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 60. Molnova Lasmiditan Succinate Product Offerings
Table 61. Molnova Recent Development
Table 62. Excenen Pharmatech Company Information
Table 63. Excenen Pharmatech Introduction and Business Overview
Table 64. Excenen Pharmatech Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 65. Excenen Pharmatech Lasmiditan Succinate Product Offerings
Table 66. Excenen Pharmatech Recent Development
Table 67. Hubei Gedian Humanwell Pharma Company Information
Table 68. Hubei Gedian Humanwell Pharma Introduction and Business Overview
Table 69. Hubei Gedian Humanwell Pharma Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 70. Hubei Gedian Humanwell Pharma Lasmiditan Succinate Product Offerings
Table 71. Hubei Gedian Humanwell Pharma Recent Development
Table 72. Nantong HI-FUTURE Biology Company Information
Table 73. Nantong HI-FUTURE Biology Introduction and Business Overview
Table 74. Nantong HI-FUTURE Biology Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. Nantong HI-FUTURE Biology Lasmiditan Succinate Product Offerings
Table 76. Nantong HI-FUTURE Biology Recent Development
Table 77. ShiJiaZhuang Chirals Chemical Company Information
Table 78. ShiJiaZhuang Chirals Chemical Introduction and Business Overview
Table 79. ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80. ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Product Offerings
Table 81. ShiJiaZhuang Chirals Chemical Recent Development
Table 82. Shenzhen Shengda Pharma Limited Company Information
Table 83. Shenzhen Shengda Pharma Limited Introduction and Business Overview
Table 84. Shenzhen Shengda Pharma Limited Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. Shenzhen Shengda Pharma Limited Lasmiditan Succinate Product Offerings
Table 86. Shenzhen Shengda Pharma Limited Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Lasmiditan Succinate Downstream Customers
Table 90. Lasmiditan Succinate Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Lasmiditan Succinate Product Picture
Figure 2. Global Lasmiditan Succinate Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Lasmiditan Succinate Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Lasmiditan Succinate Sales Volume (2020-2031) & (Kg)
Figure 5. Global Lasmiditan Succinate Sales Price (2020-2031) & (US$/g)
Figure 6. Lasmiditan Succinate Report Years Considered
Figure 7. Global Lasmiditan Succinate Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Lasmiditan Succinate Players Sales Volume Ranking (2024) & (Kg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lasmiditan Succinate Revenue in 2024
Figure 10. Lasmiditan Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Purity ≥98% Picture
Figure 12. Purity ≥99% Picture
Figure 13. Global Lasmiditan Succinate Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Lasmiditan Succinate Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Lasmiditan Succinate Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
Figure 16. Global Lasmiditan Succinate Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Lasmiditan Succinate Price by Type (2020-2031) & (US$/g)
Figure 18. Product Picture of Tablet
Figure 19. Product Picture of Oral Liquid
Figure 20. Global Lasmiditan Succinate Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Lasmiditan Succinate Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Lasmiditan Succinate Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
Figure 23. Global Lasmiditan Succinate Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Lasmiditan Succinate Price by Application (2020-2031) & (US$/g)
Figure 25. North America Lasmiditan Succinate Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Lasmiditan Succinate Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Lasmiditan Succinate Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Lasmiditan Succinate Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Lasmiditan Succinate Sales Volume (%), (2020-2031)
Figure 37. United States Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Lasmiditan Succinate Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Lasmiditan Succinate Sales Value by Application (%), 2024 VS 2031
Figure 43. China Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
Figure 45. China Lasmiditan Succinate Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Lasmiditan Succinate Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Lasmiditan Succinate Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Lasmiditan Succinate Sales Value by Application (%), 2024 VS 2031
Figure 55. India Lasmiditan Succinate Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Lasmiditan Succinate Sales Value by Type (%), 2024 VS 2031
Figure 57. India Lasmiditan Succinate Sales Value by Application (%), 2024 VS 2031
Figure 58. Lasmiditan Succinate Industrial Chain
Figure 59. Lasmiditan Succinate Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Lasmiditan Succinate market?
The top companies in the global Lasmiditan Succinate market are Molnova、Excenen Pharmatech、Hubei Gedian Humanwell Pharma.
Related Reports
Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 126
USD 3950.00
(Single User License)
Global Lasmiditan Succinate Market Research Report 2026
The global Lasmiditan Succinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 127
USD 2900.00
(Single User License)
Global Lasmiditan Succinate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 80
USD 4250.00
(Single User License)
Global Lasmiditan Succinate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 137
USD 4900.00
(Single User License)
Global Lasmiditan Succinate Market Research Report 2025
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 93
USD 2900.00
(Single User License)
Global Lasmiditan Succinate Market Insights, Forecast to 2030
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published Date: 2024-04-15
Pages: 90
USD 4900.00
(Single User License)
Global Lasmiditan Succinate Market Research Report 2024
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published Date: 2024-01-17
Pages: 92
USD 2900.00
(Single User License)
Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 126
USD 3950.00 (Single User License)Global Lasmiditan Succinate Market Research Report 2026
The global Lasmiditan Succinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 127
USD 2900.00 (Single User License)Global Lasmiditan Succinate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 80
USD 4250.00 (Single User License)Global Lasmiditan Succinate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 137
USD 4900.00 (Single User License)Global Lasmiditan Succinate Market Research Report 2025
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 93
USD 2900.00 (Single User License)Global Lasmiditan Succinate Market Insights, Forecast to 2030
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published: 2024-04-15
Pages: 90
USD 4900.00 (Single User License)Global Lasmiditan Succinate Market Research Report 2024
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published: 2024-01-17
Pages: 92
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now